Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

NCT06824883 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK/T-cell Lymphoma

Interventions

DRUG: Immunochemotherapy

Sponsor

Peking Union Medical College Hospital